M - Index
In this guide
In this guideOn this page
Skip the menu of subheadings on this page.|
Subject: Malachite Green |
Year |
Page |
|
In farmed trout, voluntary sampling programme |
1993 |
14 |
|
Update on sampling and 1993 report |
1995 |
12 |
|
COM evaluation, including Leucomalachite green |
1999 |
47 |
|
mutagenicity of |
2003 |
130 |
|
and Leucomalachite Green |
2004 |
138, 152, 182 |
|
in Farmed fish |
1999 |
23 |
|
Subject: Malathion (insecticide) |
Year |
Page |
|
COM and COC evaluation of use in insecticides and human medicinal use, in vivo studies in rats and mice |
2002 |
84, 126 |
|
in-vivo oral rat liver UDS assay |
2003 |
132 |
|
Subject: Male reproductive system |
Year |
Page |
|
Adverse trends in the development of |
2003 |
21 |
|
Adverse trends in the development of the male reproductive system |
2004 |
7, 32 |
|
Development and function in adulthood of the male reproductive system: |
2006 |
8, 47 |
|
Subject: Man-made mineral fibres |
Year |
Page |
|
(MMMFS: Glass Fibres, Rock and Slag Wool, but not Refractory Ceramic Fibres) |
1994 |
38 |
|
(MMMFs: Glass fibres, rock and Slag wool excluding Refractory Ceramic Fibres) |
1996 |
65 |
|
Refractory ceramic fibres |
1995 |
68 |
|
Subject: Manganese in the infant diet |
Year |
Page |
|
Lay summary, discussion paper and draft statement had not yet been placed in the public domain |
2018 |
27 |
|
a range of effects on the nervous system |
2019 |
11 |
|
Subject: Marine biotoxins |
Year |
Page |
|
discussion on the risk assessment and monitoring of |
2005 |
17 |
|
Risk assessment of Okadaic acid, Pectenotoxin, Azaspiracid, Yessotoxin |
2006 |
13, 156 |
|
Subject: Maternal health |
Year |
Page |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and |
2020 |
32 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, prioritisation of xenobiotics |
2021 |
30 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, alcohol; 2016 Chief Medical Officers Report |
2021 |
31 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, vitamin D |
2021 |
31 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, cadmium |
2021 |
31 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, vitamin A |
2021 |
33 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, ginger |
2021 |
33 |
|
ongoing work on the COT contribution to the SACN risk assessment on nutrition and, iodine |
2021 |
34 |
|
Hypospadias and maternal nutrition |
1999 |
19 |
|
Maternal and infant dietary exposures and risk of development of atopic outcomes and autoimmune disease. |
2017 |
26 |
|
Subject: Mathematical modelling |
Year |
Page |
|
Applications in toxicology |
1999 |
27 |
|
Subject: Meglumine |
Year |
Page |
|
Flunixin, meglumine and Flunixin-megulimine |
2003 |
129 |
|
mutagenicity of |
2005 |
87, 119 |
|
Subject: Mercury in fish and shellfish |
Year |
Page |
|
Survey of; neurotoxicity in foetuses and neonates |
2002 |
17 |
|
reconsideration of 2002 COT opinion |
2003 |
12 |
|
Subject: Metals and other elements |
Year |
Page |
|
in infant food |
1999 |
27 |
|
in infant foods |
2003 |
12 |
|
in infant foods, Survey of |
2017 |
27 |
|
Statement on the results of the 2014 survey of |
2018 |
11 |
|
in the 2000 Total Diet Study |
2003 |
12 |
|
Biological effects of wear debris generated from metal on metal on metal bearing surfaces |
2006 |
232, 241 |
|
2006 UK Total Diet Study |
2008 |
16, 170 |
|
Subject: Methanol |
Year |
Page |
|
Methanol – chronic toxicity |
2010 |
28 |
|
Effects of chronic dietary exposure to methanol |
2011 |
10 |
|
Subject: Methylation |
Year |
Page |
|
transgenerational effects of |
2006 |
236 |
|
Subject: Methylcyclopentadienyl manganese tricarbonyl |
Year |
Page |
|
Petrol additive |
1999 |
29 |
|
Subject: 1- Methylcyclopropene (plant growth regulator) |
Year |
Page |
|
Impurities in |
2003 |
191 |
|
Subject: Methylgloxal |
Year |
Page |
|
Methylglyoxal |
2009 |
16, 76 |
|
Subject: Microbiome |
Year |
Page |
|
COC evaluation of |
2020 |
62 |
|
Subject: Microenvironment |
Year |
Page |
|
Of tumours |
2020 |
63 |
|
Subject: Microplastics |
Year |
Page |
|
Review of, |
2019 |
16 |
|
Statement on the potential risks of exposure from microplastics |
2020 |
13 |
|
Overarching statement on the potential risks of exposure from microplastics |
2021 |
9 |
|
Sub-statement on the potential risks of exposure from microplastics: oral route |
2021 |
10 |
|
Subject: Milk |
Year |
Page |
|
Persistent environmental chemicals in human |
2009 |
223 |
Risk assessment of potential constituents and contaminants in cow’s milk |
2021 |
37 |
|
Subject: Mineral hydrocarbons |
Year |
Page |
|
In food, COT conclusions |
1993 |
15 |
|
Subject: Mixtures |
Year |
Page |
|
Chemical |
2008 |
229, 236 |
|
an appraisal of a report on “State of the Art on Mixture Toxicity” |
2010 |
15 |
|
Carcinogenicity of |
2008 |
284 |
|
Carcinogenicity of |
2010 |
57 |
|
IGHRC guidance document |
2007 |
21 |
|
Subject: 3-Monochloro-propane 1,2-diol (3-MCPD) |
Year |
Page |
|
COM evaluation of, in vitro and in vivo toxicity |
1999 |
48 |
|
Drinking water, food and ingredients, COM and COC updated in vitro and in vivo toxicity |
2000 |
61, 102 |
|
Subject: Mouse assay |
Year |
Page |
|
Mouse lymphoma assay, Presentation by Dr Jane Cole |
1997 |
77 |
|
Mouse bioassay, atypical results in the lipophilic shellfish toxin mouse bioassay |
2004 |
8 |
|
Mouse carcinogenicity bioassay |
1997 |
70, 117 |
|
Mouse Spot Test |
1992 |
44 |
|
Subject: Multi-element survey |
Year |
Page |
|
in various items in the diet |
1998 |
15 |
|
of wild fungi and blackberries |
1999 |
28 |
|
Subject: Multiple Chemical Sensitivity |
Year |
Page |
|
In patients, COT evaluation |
1999 |
30 |
|
In patients, COT evaluation update |
2000 |
21 |
|
Multi-strain assays |
2009 |
16 |
|
Subject: Municipal solid waste incinerators in Great Britain, Cancer incidence near |
Year |
Page |
|
COC evaluation of over 14 million people living near to 72 MWIs, liver cancer |
2000 |
104 |
|
Update review of epidemiological studies |
2008 |
284 |
|
considered three further papers on this topic published since the 2009 review |
2011 |
54 |
|
Subject: Mutagenicity |
Year |
Page |
|
Comet assay |
2006 |
239, 249 |
|
UDS assay |
2006 |
239, 249 |
|
Halonitromethanes (HNMs) |
2005 |
85, 116 |
|
Historical control data in mutagenicity studies |
1996 |
47 |
|
Mutagenicity |
2012 |
36 |
|
Joint symposium with COM on use of target organ mutagenicity in carcinogen risk assessment |
2004 |
192 |
|
Joint meeting of COT/COM on use of target organ mutagenicity assays in carcinogen risk assessment |
2005 |
92, 124 |
|
Review of current approaches to germ cell mutagenicity testing |
2013 |
45 |
|
Significance of environmental mutagenesis |
2004 |
141 |
|
Significance of in vivo mutagenicity at high doses |
2003 |
139 |
|
Organ mutagencity data in carcinogen risk assessment |
2005 |
124 |
|
Subject: Mutagenicity testing strategies |
Year |
Page |
|
for new substances |
1991 |
33 |
|
on New Substances: Further Advice to HSE |
1992 |
43 |
|
In vitro mammalian cell mutation assays |
2003 |
137 |
|
Review of current approaches to germ cell mutagenicity testing |
2013 |
45 |
|
‘Risk assessment methodologies and approaches for mutagenic and carcinogenic substances’, Preliminary Report by the EU Scientific Committees on Consumer Products, on Health and Environmental Risks, and on Emerging and Newly-Identified Risks on |
2008 |
280 |
|
Subject: Mutagens |
Year |
Page |
|
classifications of |
1992 |
43 |
|
Thresholds for in vivo |
2010 |
41 |
|
Classification of chemicals on the basis of mutagenic properties |
1992 |
43 |
|
International workshop on the categorisation of mutagens |
2001 |
108 |
|
Mutational spectra |
2014 |
35 |
|
signatures of environmental mutagens, presentation on mutational spectra and, |
2020 |
48 |
|
Mutational signatures associated with tobacco smoking in human cancer- and associated editorial paper |
2017 |
53 |
|
Muta®mouse and Big Blue transgenic rodent assay systems |
2005 |
12434 |
|
Risk assessment of in vivo mutagens (and genotoxic mutagens) |
2001 |
107 |
|
Subject: Mutational spectra |
Year |
Page |
|
Statement on the use of mutation spectra in genetic toxicology |
2015 |
35 |
|
Mutational spectra |
1999 |
51, 72 |
|
Subject: Mycotoxins |
Year |
Page |
|
Prioritization of micro-components of the diet for further toxicity testing or surveillance |
1991 |
31, 48 |
|
In cheese |
2006 |
9 |
|
Statement on the potential risks of combined exposure to mycotoxins |
2020 |
18 |
|
Statement on the potential risks of combined exposure to mycotoxins |
2021 |
7 |
|
Moniliformin in maize and maize products |
1998 |
14 |